Compare CRESY & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRESY | INMD |
|---|---|---|
| Founded | 1936 | 2008 |
| Country | Argentina | Israel |
| Employees | 2889 | N/A |
| Industry | Real Estate | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 718.2M | 842.0M |
| IPO Year | N/A | 2018 |
| Metric | CRESY | INMD |
|---|---|---|
| Price | $11.69 | $13.38 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.33 |
| AVG Volume (30 Days) | 273.7K | ★ 674.0K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 8.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.74 |
| Revenue Next Year | N/A | $3.26 |
| P/E Ratio | ★ $6.92 | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.39 | $12.72 |
| 52 Week High | $14.21 | $16.74 |
| Indicator | CRESY | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 50.65 | 38.70 |
| Support Level | $10.90 | $13.29 |
| Resistance Level | $12.26 | $13.87 |
| Average True Range (ATR) | 0.58 | 0.21 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 42.31 | 4.12 |
Cresud SACIF y A is a Latin American agricultural firm producing basic commodities with a growing presence in Argentina, Brazil, and other countries through its investment in Brasilagro. It focuses on grains, sugarcane, and cattle farming, acquiring and developing agricultural properties for production or value appreciation, and occasionally selling appreciated land. It also leases land and offers agency and agro-industrial services. Operations are divided into two segments: agricultural business (production, land transformation and sales, corporate services) and urban properties and investments (shopping malls, offices, sales, developments, hotels, and related activities).
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.